Skip to main content

Bezlotoxumab use as adjunctive therapy with the third fecal microbiota transplant in refractory recurrent Clostridium difficilecolitis; a case report and concise literature review

Kaako, A., Al-Amer, M., & Abdeen, Y. (2019). Bezlotoxumab use as adjunctive therapy with the third fecal microbiota transplant in refractory recurrent Clostridium difficile colitis; a case report and concise literature review. Anaerobe, 55, 112-116. doi:10.1016/j.anaerobe.2018.11.010

2019

Leave a Reply

Your email address will not be published. Required fields are marked *